Abstract: An object of the present invention is to provide a method for producing PHA, which is capable of suppressing the cost of overall production equipment including a waste water treatment process in production of PHA using microorganisms. Provided is a method including: a production step of purifying or molding polyhydroxyalkanoic acid biosynthesized in bacterial cells of a microorganism; a discharge step of discharging waste water containing nitrogen-containing impurities from the production step; and a nitrogen removal step of biologically treating the waste water to remove the nitrogen-containing impurities from the waste water. In the method, the residual ratio of the polyhydroxyalkanoic acid in the production step is 99% by weight or less, and the waste water that is biologically treated in the nitrogen removal step contains the polyhydroxyalkanoic acid in addition to the nitrogen-containing impurities.

Abstract: An indwelling device for embolization comprises a coil portion (11) having a proximal side and a distal side and having a lumen extending in a longitudinal direction, a stretch-resistant member (20) disposed in the lumen, wherein the indwelling device has a fixing structure in which the stretch-resistant member (20) is knotted to the detachable portion attached in the lumen of a proximal end part of the coil portion (11) and extending proximally from a proximal end of the lumen, in order for the stretch-resistant member (20) to be more securely anchored to the coil portion (11).

Abstract: A resin composition contains a polyimide resin and an ester-based resin. The ester-based resin is polycarbonate or polyarylate. The polyimide contains a structural unit represented by general formula (1). In general formula (1), X is a divalent organic group shown in group (I), and Y is a divalent group that contains one or more selected from the group consisting of a fluorine group, a trifluoromethyl group, a sulfonic group, a fluorene structure and an alicyclic structure. Each of R1 and R2 is a fluorine atom, an alkyl group having 1 to 20 carbon atoms, or a fluoroalkyl group having 1 to 20 carbon atoms, m is an integer of 1 to 4, and n is an integer of 0 to 4.

Abstract: A tubular medical instrument which can be easily ejected from a transfer device and accurately placed in a case the tubular medical instrument is released from the transfer device and placed at an affected area is provided. A tubular medical instrument includes ends portions, and a central portion, wherein each of the end portions is a region including one axial end of the tubular medical instrument and having a length of 10% with respect to an axial length L1 of the tubular medical instrument, the central portion is a region including an axial center of the tubular medical instrument and having a length of 10% with respect to the axial length L1 of the tubular medical instrument, and a ratio (difference V/difference W) is 3 or more.

Abstract: The present application provides: a suppressor of pluripotent stem cell aggregation for use in suspension culture of pluripotent stem cells, comprising a cell cycle arresting agent; a method for producing a pluripotent stem cell aggregate(s), comprising a step of subjecting pluripotent stem cells to suspension culture in a culture medium comprising the suppressor; a pluripotent stem cell aggregate obtained by the method; and a composition for culture of pluripotent stem cells comprising a cell aggregate(s) of pluripotent stem cells, a culture medium, and a cell cycle arresting agent. According to the method, it is possible, in suspension culture of pluripotent stem cells, to produce a cell aggregate(s) with high cell viability and appropriate size in a high yield while maintaining the undifferentiated state of the cells and suppressing the aggregation.

Abstract: A method for producing a poly(3-hydroxybutyrate) resin-containing composition for melt processing includes: heating a material containing a poly(3-hydroxybutyrate) resin to a temperature equal to or higher than a melting point peak temperature in differential scanning calorimetry analysis of the poly(3-hydroxybutyrate) resin and equal to or lower than a melting point peak end temperature in the differential scanning calorimetry analysis of the poly(3-hydroxybutyrate) resin, wherein the difference between the melting point peak temperature and the melting point peak end temperature of the poly(3-hydroxybutyrate) resin is 10° C. or more; and extruding the heated material to obtain a composition for melt processing that has a new crystallization peak at a temperature higher than the melting point peak temperature.

Abstract: A method for producing lipid particles, including: injecting molten lipids directly into a liquid at a temperature lower than a melting point of the lipids through a liquid supply port of a two-fluid nozzle while injecting a gas directly into the liquid through a gas supply port of the two-fluid nozzle, so that the molten lipids are dispersed and atomized into particles in the liquid due to the gas and the particles are solidified to form lipid particles. The lipids have a water solubility of 10 g/L or less at 25° C. and are solid at 25° C. The two-fluid nozzle is heated to a temperature at least 10° C. higher than the melting point of the lipids. A ratio D50/Nd of a volume median diameter D50 of the lipid particles to an orifice diameter Nd of the liquid supply port of the two-fluid nozzle is 0.0017 or more and 0.17 or less.

Abstract: A method for producing an injection-molded body from a molding material containing a poly(3-hydroxybutyrate) resin includes: melting the molding material by heating the molding material to a temperature between a melting point peak temperature and a melting point peak end temperature in differential scanning calorimetry analysis of the molding material, wherein the difference between the melting point peak temperature and the melting point peak end temperature of the molding material is from 10 to 70° C.; injecting the molten molding material into a mold having a temperature of 30 to 80° C.; and cooling the molding material in the mold to crystallize and solidify the molding material.

Abstract: A method for producing expanded particles having a high expansion ratio by a pressure-release expansion with a simpler configuration and at a low facility cost is provided. A production device includes an expansion cylinder being provided with a connecting port that connects with open-system branch cylinder and having a space of a saturated steam atmosphere. The space of a saturated steam atmosphere may be a different space from a space inside the branch cylinder. A temperature (T1) inside the expansion chamber exceeds 102° C. and is not higher than a higher one of 108° C. and a temperature obtained by a melting point Tm of a thermoplastic resin minus 14° C. A temperature (T2) at a connecting port is not lower than 100° C., and the temperature (T1) is higher than the temperature (T2).

Abstract: Endoscope forceps contains: a coil member having a distal end and a proximal end and including a lumen, the coil member made of a metal and having flexibility; a tubular member including a lumen and disposed in the lumen of the coil member; a pair of forceps members disposed on a distal side relative to the coil member, and openable and closable; connection members respectively connected to portions on a proximal side of the pair of forceps members; and a stranded wire inserted through the lumen of the tubular member and including a connection portion connected to proximal end portions of the connection members, wherein the distal end of the coil member is located between a distal end of the tubular member and the connection portion at which each connection member is connected to the stranded wire.

Abstract: A solar cell module which exhibits high output while ensuring connection strength between solar cells; and a solar cell suitable for the solar cell module. In the solar cell, a region on a first surface and at a first edge of a substrate that is not covered by a p-type transparent oxide electrode layer is defined as a “region A,” and a region on the first surface and at a second edge opposite to the first edge of the substrate and not covered by the p-type transparent oxide electrode layer is defined as a “region B.” The area of the region A is larger than the area of the region B.

Abstract: An object of the present invention is to provide highly proliferative mesenchymal stem cells (MSCs) useful for the large-scale and rapid production of a cell preparation, and a cell population comprising the mesenchymal stem cells. According to the present invention, there is provided a cell population comprising mesenchymal stem cells derived from the fetal appendage, wherein, in the cell population, the proportion of CD105+ mesenchymal stem cells is 50% or more, the proportion of CD200+ mesenchymal stem cells is less than 10%, and the proportion of CD106+ mesenchymal stem cells is less than 5%.

Abstract: A photoelectric conversion device for detecting the spot size of incident light, includes a photoelectric conversion element having a photoelectric conversion substrate with two main surfaces, and first and second sensitivity section sections; and scanners that relatively scan incident light on the main surfaces of the photoelectric conversion element. When a sensitivity region on a main surface of the first sensitivity section is defined as a first sensitivity region and sensitivity regions that appear on a main surface of the second sensitivity sections are defined as second sensitivity regions, the first sensitivity region receives at least part of the light incident on the main surface during scanning, and has a pattern in which, in accordance with enlargement of an irradiation region irradiated with incident light on the main surface, the proportion of the first sensitivity region with respect to the second sensitivity regions in the irradiation region is decreased.

Abstract: A method of producing a graphite product using high-temperature heat treatment is capable of producing a high-quality graphite product without using any resin as a raw material or without the need for the resin used to be a special kind of resin. The method of producing a graphite product includes a step of heat-treating a raw material at a temperature of 2400° C. or higher. The raw material contains graphene oxide (A) and optionally a resin (B). The graphene oxide (A) has a carbon-to-oxygen mass ratio (C/O) of 0.1 to 20. In the raw material, the content of the graphene oxide (A) may be from 0.3 to 20% by weight or may be from 50 to 100% by weight. The graphene oxide (A) may have an average particle size of 2 to 40 ?n.

Abstract: This invention provides a cell population comprising mesenchymal cells capable of forming a cell sheet that can be spontaneously detached from a substrate. In such cell population comprising mesenchymal cells, the proportion of cells positive for CD324 is 70% or more and the proportion of mesenchymal cells positive for CD90 is 90% or more.

Abstract: A pile fabric includes a long pile portion and a short pile portion. An average pile length of the long pile portion differs from an average pile length of the short pile portion by 2 mm or more. The long pile portion contains crimped polyester-based fibers in an amount of 60% by weight or more. The short pile portion contains crimped polyester-based fibers in an amount of 60% by weight or more. A crimp removal temperature of the polyester-based fibers of the long pile portion is lower than a crimp removal temperature of the polyester-based fibers of the short pile portion. The crimp removal temperature of the polyester-based fibers of the short pile portion is 90° C. or more and 120° C. or less. Each of the crimp removal temperatures indicates a minimum temperature that satisfies a specific relationship. A method for manufacturing the pile fabric is also provided.

Abstract: An object of the present invention is to provide an environmentally friendly drilling fluid that has excellent cuttings transport capability and excellent hole cleaning capability. A drilling fluid according to the present disclosure is a drilling fluid containing water, biodegradable fibers, and a thickener. The thickener contains a biodegradable polysaccharide. The content of the biodegradable polysaccharide in the drilling fluid is greater than or equal to 0.01 g/L and less than or equal to 5 g/L.

Abstract: A light therapy diagnostic device comprising a shaft, an optical waveguide disposed in a lumen of the shaft and being movable forward and backward in a longitudinal direction of the shaft, and a transparent member disposed in the lumen and located distal to the optical waveguide, wherein: the optical waveguide guides a first light and a second light; the shaft has a lateral emission window which allows the first light and the second light to be emitted toward a lateral direction and a distal emission window which allows the first light to be emitted toward a distal direction; the optical waveguide includes a core and a clad, wherein a distal end surface of the core is inclined with respect to an optical axis of the optical waveguide; the first light passes through the transparent member in a state where the optical waveguide is in contact with the transparent member.

Abstract: This catheter has: a shaft (10) has a first side hole (31) and a second side hole (32) in a wall (12); an insertion member (20) disposed in the lumen (11) of the shaft (10); a first electrode (41) provided on outer side of the first side hole (31); and a first wire (51) that is electrically connected to the first electrode (41) through the first side hole (31) and extents in the lumen (11) of the shaft (10) but outside the insertion member (20), wherein the first wire (51) has a first position (61) and a second position (62) inside the shaft (10), and the second position (62) of the first wire (51) is located at a position deviated from the first position (61) by 45 degrees or more in a circumferential direction of the insertion member (20).

Abstract: An object of the present invention is to provide a method for producing a mesenchymal stromal cell composition, comprising conveniently and aseptically separating high-purity amnion-derived MSCs by performing enzyme treatment only once. According to the present invention, the following are provided: a method for producing a mesenchymal stromal cell composition, comprising: performing enzyme treatment of an amnion with collagenase and thermolysin and/or dispase; and filtering the enzyme-treated amnion through a mesh; a method for producing a cryopreserved mesenchymal stromal cell composition; and a therapeutic agent comprising as an active ingredient the mesenchymal stromal cell composition for a disease selected from graft-versus-host disease, inflammatory bowel disease, systemic lupus erythematosus, liver cirrhosis, or radiation enteritis.